Publication | Closed Access
Capecitabine in association with epirubicin and docetaxel as first line chemotherapy in advanced breast cancer A dose-finding study
10
Citations
0
References
2000
Year
Dose-finding StudyFirst Line ChemotherapyAdvanced Breast CancerBreast OncologyMedicinePharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentOncology
No additional data available for this publication yet. Check back later!